nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—Heat stroke—Propantheline—pancreatitis	0.0984	0.323	CcSEcCtD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CX3CL1—pancreatitis	0.0252	0.0362	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—TACR1—pancreatitis	0.0191	0.0275	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—CCKAR—pancreatitis	0.0188	0.027	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—BDKRB2—pancreatitis	0.014	0.0201	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—SMO—pancreatitis	0.0138	0.0198	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL5—pancreatitis	0.0133	0.0191	CbGpPWpGaD
Maraviroc—Laryngitis—Hyoscyamine—pancreatitis	0.0128	0.0419	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—IL18—pancreatitis	0.0126	0.0181	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—PPY—pancreatitis	0.0125	0.018	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—CNR1—pancreatitis	0.0116	0.0167	CbGpPWpGaD
Maraviroc—Abdominal distension—Propantheline—pancreatitis	0.0113	0.0373	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—PPY—pancreatitis	0.0106	0.0152	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—HLA-DRB1—pancreatitis	0.0101	0.0145	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CX3CL1—pancreatitis	0.00948	0.0136	CbGpPWpGaD
Maraviroc—Respiratory failure—Hyoscyamine—pancreatitis	0.00937	0.0308	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCK—pancreatitis	0.00922	0.0133	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL2—pancreatitis	0.00915	0.0132	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—TACR1—pancreatitis	0.00899	0.0129	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCKAR—pancreatitis	0.00884	0.0127	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH4—pancreatitis	0.00844	0.0121	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.00839	0.0121	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CASR—pancreatitis	0.00815	0.0117	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR2A—pancreatitis	0.00794	0.0114	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—MTNR1B—pancreatitis	0.00778	0.0112	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CNR2—pancreatitis	0.00758	0.0109	CbGpPWpGaD
Maraviroc—Eczema—Hyoscyamine—pancreatitis	0.00743	0.0244	CcSEcCtD
Maraviroc—Nasal congestion—Hyoscyamine—pancreatitis	0.00733	0.0241	CcSEcCtD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL8—pancreatitis	0.00723	0.0104	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.00722	0.0104	CbGpPWpGaD
Maraviroc—Amnesia—Hyoscyamine—pancreatitis	0.00711	0.0233	CcSEcCtD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.00704	0.0101	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—SST—pancreatitis	0.00699	0.01	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.00692	0.00995	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—BDKRB2—pancreatitis	0.00657	0.00945	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—pancreatitis	0.00657	0.00944	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PPY—pancreatitis	0.00639	0.00918	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.00636	0.00914	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.00629	0.00905	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.00619	0.00889	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.00619	0.00889	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.00603	0.00867	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.00603	0.00867	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—KNG1—pancreatitis	0.00598	0.00859	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.00593	0.00853	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—SST—pancreatitis	0.0059	0.00848	CbGpPWpGaD
Maraviroc—Abdominal distension—Hyoscyamine—pancreatitis	0.00581	0.0191	CcSEcCtD
Maraviroc—Insomnia—Propantheline—pancreatitis	0.0058	0.019	CcSEcCtD
Maraviroc—Angina pectoris—Hyoscyamine—pancreatitis	0.00562	0.0185	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—BDKRB2—pancreatitis	0.00554	0.00797	CbGpPWpGaD
Maraviroc—Constipation—Propantheline—pancreatitis	0.00548	0.018	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—CNR1—pancreatitis	0.00544	0.00782	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.00514	0.0074	CbGpPWpGaD
Maraviroc—Depression—Hyoscyamine—pancreatitis	0.00513	0.0169	CcSEcCtD
Maraviroc—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00507	0.0167	CcSEcCtD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.00505	0.00726	CbGpPWpGaD
Maraviroc—Myocardial infarction—Hyoscyamine—pancreatitis	0.00504	0.0166	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—KNG1—pancreatitis	0.00504	0.00725	CbGpPWpGaD
Maraviroc—Conjunctivitis—Hyoscyamine—pancreatitis	0.005	0.0164	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL5—pancreatitis	0.005	0.00719	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—SCT—pancreatitis	0.00494	0.0071	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CASR—pancreatitis	0.00494	0.0071	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CX3CL1—pancreatitis	0.00484	0.00696	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—pancreatitis	0.00475	0.00683	CbGpPWpGaD
Maraviroc—Hypersensitivity—Propantheline—pancreatitis	0.00472	0.0155	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—MTNR1B—pancreatitis	0.00471	0.00677	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCK—pancreatitis	0.00471	0.00677	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00469	0.00674	CbGpPWpGaD
Maraviroc—Asthenia—Propantheline—pancreatitis	0.0046	0.0151	CcSEcCtD
Maraviroc—Hallucination—Hyoscyamine—pancreatitis	0.0046	0.0151	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CNR2—pancreatitis	0.00459	0.0066	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—TACR1—pancreatitis	0.00459	0.0066	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCKAR—pancreatitis	0.00452	0.00649	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	0.00443	0.00638	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.00441	0.00634	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.00433	0.00622	CbGpPWpGaD
Maraviroc—CCR5—Disease—CTRB2—pancreatitis	0.00429	0.00617	CbGpPWpGaD
Maraviroc—Dizziness—Propantheline—pancreatitis	0.00424	0.0139	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—CCL5—pancreatitis	0.00422	0.00606	CbGpPWpGaD
Maraviroc—Vomiting—Propantheline—pancreatitis	0.00408	0.0134	CcSEcCtD
Maraviroc—Mental disorder—Hyoscyamine—pancreatitis	0.00405	0.0133	CcSEcCtD
Maraviroc—Rash—Propantheline—pancreatitis	0.00404	0.0133	CcSEcCtD
Maraviroc—Dermatitis—Propantheline—pancreatitis	0.00404	0.0133	CcSEcCtD
Maraviroc—Erythema—Hyoscyamine—pancreatitis	0.00402	0.0132	CcSEcCtD
Maraviroc—Headache—Propantheline—pancreatitis	0.00402	0.0132	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.00401	0.00576	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PTHLH—pancreatitis	0.0039	0.00561	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—SMO—pancreatitis	0.0039	0.00561	CbGpPWpGaD
Maraviroc—Nausea—Propantheline—pancreatitis	0.00381	0.0125	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—pancreatitis	0.00369	0.0053	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PPY—pancreatitis	0.00361	0.00519	CbGpPWpGaD
Maraviroc—Syncope—Hyoscyamine—pancreatitis	0.00361	0.0118	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—SST—pancreatitis	0.00357	0.00513	CbGpPWpGaD
Maraviroc—Loss of consciousness—Hyoscyamine—pancreatitis	0.00353	0.0116	CcSEcCtD
Maraviroc—Convulsion—Hyoscyamine—pancreatitis	0.00348	0.0114	CcSEcCtD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.00345	0.00496	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL2—pancreatitis	0.00344	0.00495	CbGpPWpGaD
Maraviroc—Anxiety—Hyoscyamine—pancreatitis	0.00341	0.0112	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—BDKRB2—pancreatitis	0.00336	0.00482	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.00335	0.00482	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CNR1—pancreatitis	0.00329	0.00474	CbGpPWpGaD
Maraviroc—Oedema—Hyoscyamine—pancreatitis	0.00328	0.0108	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PPY—pancreatitis	0.00328	0.00471	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRSS1—pancreatitis	0.00325	0.00468	CbGpPWpGaD
Maraviroc—Shock—Hyoscyamine—pancreatitis	0.00323	0.0106	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—GCG—pancreatitis	0.00318	0.00457	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00315	0.00453	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRSS3—pancreatitis	0.00308	0.00443	CbGpPWpGaD
Maraviroc—CCR5—Disease—PNLIP—pancreatitis	0.00308	0.00443	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—KNG1—pancreatitis	0.00305	0.00439	CbGpPWpGaD
Maraviroc—Insomnia—Hyoscyamine—pancreatitis	0.00297	0.00975	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.00296	0.00425	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—HRAS—pancreatitis	0.00291	0.00418	CbGpPWpGaD
Maraviroc—Fatigue—Hyoscyamine—pancreatitis	0.00283	0.00929	CcSEcCtD
Maraviroc—Pain—Hyoscyamine—pancreatitis	0.00281	0.00922	CcSEcCtD
Maraviroc—Constipation—Hyoscyamine—pancreatitis	0.00281	0.00922	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—SCT—pancreatitis	0.00279	0.00401	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CASR—pancreatitis	0.00279	0.00401	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—pancreatitis	0.00278	0.004	CbGpPWpGaD
Maraviroc—CCR5—Disease—LTF—pancreatitis	0.00277	0.00398	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL8—pancreatitis	0.00272	0.00391	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00268	0.00881	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—MTNR1B—pancreatitis	0.00266	0.00383	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCK—pancreatitis	0.00266	0.00383	CbGpPWpGaD
Maraviroc—Abdominal pain—Hyoscyamine—pancreatitis	0.00259	0.00852	CcSEcCtD
Maraviroc—Body temperature increased—Hyoscyamine—pancreatitis	0.00259	0.00852	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CNR2—pancreatitis	0.00259	0.00373	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TACR1—pancreatitis	0.00259	0.00373	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00256	0.00368	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL5—pancreatitis	0.00255	0.00367	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCKAR—pancreatitis	0.00255	0.00367	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SCT—pancreatitis	0.00253	0.00364	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CASR—pancreatitis	0.00253	0.00364	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CX3CL1—pancreatitis	0.00248	0.00357	CbGpPWpGaD
Maraviroc—Hypersensitivity—Hyoscyamine—pancreatitis	0.00242	0.00794	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CCK—pancreatitis	0.00242	0.00347	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—MTNR1B—pancreatitis	0.00242	0.00347	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00238	0.00342	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CNR2—pancreatitis	0.00236	0.00339	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TACR1—pancreatitis	0.00236	0.00339	CbGpPWpGaD
Maraviroc—Asthenia—Hyoscyamine—pancreatitis	0.00235	0.00773	CcSEcCtD
Maraviroc—Pruritus—Hyoscyamine—pancreatitis	0.00232	0.00763	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CCKAR—pancreatitis	0.00232	0.00333	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.00231	0.00332	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL8—pancreatitis	0.0023	0.0033	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—pancreatitis	0.00225	0.00324	CbGpPWpGaD
Maraviroc—Diarrhoea—Hyoscyamine—pancreatitis	0.00225	0.00737	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PTHLH—pancreatitis	0.00221	0.00317	CbGpPWpGaD
Maraviroc—Dizziness—Hyoscyamine—pancreatitis	0.00217	0.00713	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PNLIP—pancreatitis	0.00216	0.0031	CbGpPWpGaD
Maraviroc—Vomiting—Hyoscyamine—pancreatitis	0.00209	0.00685	CcSEcCtD
Maraviroc—Rash—Hyoscyamine—pancreatitis	0.00207	0.0068	CcSEcCtD
Maraviroc—Dermatitis—Hyoscyamine—pancreatitis	0.00207	0.00679	CcSEcCtD
Maraviroc—Headache—Hyoscyamine—pancreatitis	0.00206	0.00675	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—SST—pancreatitis	0.00202	0.0029	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PTHLH—pancreatitis	0.002	0.00288	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SMO—pancreatitis	0.002	0.00288	CbGpPWpGaD
Maraviroc—Nausea—Hyoscyamine—pancreatitis	0.00195	0.0064	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PPY—pancreatitis	0.00194	0.00278	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP3CA—pancreatitis	0.00191	0.00275	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	0.00191	0.00274	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—BDKRB2—pancreatitis	0.0019	0.00273	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CNR1—pancreatitis	0.00186	0.00268	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SST—pancreatitis	0.00183	0.00263	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.00183	0.00263	CbGpPWpGaD
Maraviroc—CCR5—Disease—FGA—pancreatitis	0.00182	0.00261	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GCG—pancreatitis	0.0018	0.00258	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00177	0.00255	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL2—pancreatitis	0.00176	0.00253	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—KNG1—pancreatitis	0.00173	0.00248	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—BDKRB2—pancreatitis	0.00172	0.00248	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CNR1—pancreatitis	0.00169	0.00243	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GCG—pancreatitis	0.00163	0.00235	CbGpPWpGaD
Maraviroc—CCR5—Disease—PPP3CA—pancreatitis	0.00161	0.00232	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—KNG1—pancreatitis	0.00157	0.00225	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGG—pancreatitis	0.0015	0.00215	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SCT—pancreatitis	0.0015	0.00215	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASR—pancreatitis	0.0015	0.00215	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CX3CL1—pancreatitis	0.00147	0.00211	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL5—pancreatitis	0.00144	0.00207	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCK—pancreatitis	0.00143	0.00205	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MTNR1B—pancreatitis	0.00143	0.00205	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CNR2—pancreatitis	0.00139	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—A2M—pancreatitis	0.00139	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TACR1—pancreatitis	0.00139	0.002	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL8—pancreatitis	0.00139	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCKAR—pancreatitis	0.00137	0.00197	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.00136	0.00195	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL5—pancreatitis	0.00131	0.00188	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGA—pancreatitis	0.00127	0.00183	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—pancreatitis	0.00127	0.00183	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.00126	0.00182	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00125	0.0018	CbGpPWpGaD
Maraviroc—CCR5—Disease—PDGFA—pancreatitis	0.00122	0.00175	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTHLH—pancreatitis	0.00118	0.0017	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SMO—pancreatitis	0.00118	0.0017	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGB—pancreatitis	0.00116	0.00166	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—pancreatitis	0.00116	0.00166	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP3CA—pancreatitis	0.00113	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SST—pancreatitis	0.00108	0.00156	CbGpPWpGaD
Maraviroc—CCR5—Disease—LPL—pancreatitis	0.00108	0.00155	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DUSP6—pancreatitis	0.00107	0.00154	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.00105	0.00151	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BDKRB2—pancreatitis	0.00102	0.00146	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CNR1—pancreatitis	0.000999	0.00144	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GCG—pancreatitis	0.000964	0.00139	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000942	0.00135	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KNG1—pancreatitis	0.000926	0.00133	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL2—pancreatitis	0.000903	0.0013	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFA—pancreatitis	0.000851	0.00122	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—pancreatitis	0.000786	0.00113	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL5—pancreatitis	0.000774	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Disease—INS—pancreatitis	0.000774	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LPL—pancreatitis	0.000757	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SPP1—pancreatitis	0.000717	0.00103	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—pancreatitis	0.000714	0.00103	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—pancreatitis	0.000682	0.000981	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	0.000675	0.00097	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—ALDH2—pancreatitis	0.000663	0.000954	CbGpPWpGaD
Maraviroc—CCR5—Disease—MDM2—pancreatitis	0.000644	0.000926	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LEP—pancreatitis	0.000634	0.000912	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—pancreatitis	0.000621	0.000892	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NRAS—pancreatitis	0.000573	0.000823	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—INS—pancreatitis	0.000542	0.000779	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—pancreatitis	0.000533	0.000767	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—KRAS—pancreatitis	0.000493	0.000708	CbGpPWpGaD
Maraviroc—CCR5—Disease—NRAS—pancreatitis	0.000483	0.000694	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MDM2—pancreatitis	0.000451	0.000648	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—pancreatitis	0.000449	0.000645	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL8—pancreatitis	0.000422	0.000606	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HRAS—pancreatitis	0.000419	0.000602	CbGpPWpGaD
Maraviroc—CCR5—Disease—KRAS—pancreatitis	0.000416	0.000598	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASP3—pancreatitis	0.000404	0.00058	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—pancreatitis	0.000401	0.000576	CbGpPWpGaD
Maraviroc—CCR5—Disease—HRAS—pancreatitis	0.000353	0.000508	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NRAS—pancreatitis	0.000338	0.000486	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—pancreatitis	0.000338	0.000486	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—pancreatitis	0.000314	0.000452	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KRAS—pancreatitis	0.000291	0.000418	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CTRB2—pancreatitis	0.000268	0.000385	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HRAS—pancreatitis	0.000247	0.000356	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—pancreatitis	0.000237	0.00034	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FDX1—pancreatitis	0.000232	0.000334	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH4—pancreatitis	0.000216	0.00031	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRSS1—pancreatitis	0.000203	0.000292	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNLIP—pancreatitis	0.000192	0.000277	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRSS3—pancreatitis	0.000192	0.000277	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—XDH—pancreatitis	0.000173	0.000248	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH1B—pancreatitis	0.000161	0.000231	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLA2G1B—pancreatitis	0.000128	0.000185	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—A2M—pancreatitis	0.000124	0.000178	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH2—pancreatitis	0.000113	0.000163	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCG—pancreatitis	8.6e-05	0.000124	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPL—pancreatitis	6.75e-05	9.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—pancreatitis	4.93e-05	7.08e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INS—pancreatitis	4.83e-05	6.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—pancreatitis	4.43e-05	6.37e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—pancreatitis	3.87e-05	5.57e-05	CbGpPWpGaD
